Zantac Carcinogens Lead to Sanofi GlaxoSmithKline Investigation
Cancer-Causing in Zantac Under Investigation Zantac is a common over-the-counter medication intended to provide relief to those suffering from heartburn. Millions of Americans have used this drug to help ease this common ailment and as a result, may have been exposed to the dangerous carcinogen known as NDMA. The companies...
The post Zantac Carcinogens Lead to Sanofi GlaxoSmithKline Investigation appeared first on .
The post Zantac Carcinogens Lead to Sanofi GlaxoSmithKline Investigation appeared first on .
Submit a Comment